https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period […]

Pomerantz LLP is investigating claims on behalf of investors of XPLR Infrastructure, LP (f/k/a NextEra Energy Partners, LP)(“XPLR”or the “Company”)(NYSE: NEP).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether XPLR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Extra Duty Solutions (EDS), a leading provider of managed services for law enforcement extra duty programs, is proud to announce two key leadership promotions aimed at strengthening client relationships and enhancing product innovation. https://mma.prnewswire.com/media/2618041/Extra_Duty_Solutions_James_Starkes_and_Stacey_Kerney.jpg James Starkes was recently appointed Director of Product, bringing a strategic vision to EDS' evolving suite of services. Since joining EDS

(NYSE:SQ),(NYSE:XYZ), NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Block, Inc. (NYSE: SQ, XYZ) between February 26, 2020 and April 30, 2024, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline.

Miramar, Florida Owner Named Franchisee of the Year by International Franchise Association ANY LAB TEST NOW®, the nation's leading direct access lab testing company, proudly announces that Dr. Mac Innocent, owner of Any Lab Test Now inMiramar, Florida, has been honored as Franchisee of the Year by the International Franchise Association (IFA). The prestigious award

Pomerantz LLP is investigating claims on behalf of investors of XPLR Infrastructure, LP (f/k/a NextEra Energy Partners, LP)(“XPLR”or the “Company”)(NYSE: NEP).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether XPLR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz LLP is investigating claims on behalf of investors ofPrimis Financial Corp. (“Primis” or the “Company”)(NASDAQ: FRST).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Primis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmaceuticals, Inc.(“Zentalis” or the “Company”)(NASDAQ: ZNTL).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Zentalis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

Pomerantz LLP is investigating claims on behalf of investors of CARGO Therapeutics, Inc. (“Cargo” or the “Company”)(NASDAQ: CRGX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Cargo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors of Manhattan Associates, Inc. (“Manhattan Associates” or the “Company”) (NASDAQ: MANH).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Manhattan Associates and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.